subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now
Picture: SUPPLIED
Picture: SUPPLIED

Ascendis Health has no plans to delist, despite its move to sell three of its remaining businesses for R802m.

Business Day TV spoke to group CFO and interim CEO Cheryl-Jane Kujenga for more detail.

Or listen to full audio

Subscribe for free episodes: iono.fm | Apple Podcasts | Spotify | Pocket Casts | Player.fm

subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.